GI Dynamics gets funding for French obesity trial
21 June, 2013 by Dylan Bushell-EmblingThe French Government has agreed to fund a two-year economic impact study of GI Dynamics’ (ASX:GID) EndoBarrier Therapy in obesity and type 2 diabetes.
QBiotics launches $10m capital raising
20 June, 2013 by Dylan Bushell-EmblingQBiotics is involved in a $10m capital raising, seeking to raise funds for human studies of its anti-tumour candidate and research into the wound-healing potential of a new compound.
Grants available to partner with Massachusetts life sciences companies
20 June, 2013A new funding program has recently been announced by the State of Victoria and the Commonwealth of Massachusetts to support joint research and development (R&D) projects.
WA researchers target key plant pathogen
19 June, 2013 by Dylan Bushell-EmblingMurdoch University scientists have developed a method for using gene silencing to control root lesion nematodes - plant pathogens which cause major agricultural damage.
iSonea picks manufacturing partner for AirSonea
19 June, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has engaged a Hong Kong manufacturer to produce its AirSonea mobile wheeze monitoring device, ahead of the product’s Australian launch in September.
AusBiotech delegation of CEOs to Parliament House
18 June, 2013AusBiotech, its member CEOs and directors were yesterday hosted at Parliament House for this year’s CEO Forum, which was addressed by a range of speakers on innovation policy and programs, including the Hon Greg Combet, Minister for Climate Change, Industry and Innovation.
Pharmaxis presents new cystic fibrosis trial data
18 June, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) said CF patients receiving Bronchitol in recent phase III trials experienced fewer exacerbations long term than the control groups.
pSivida’s Iluvien close to UK reimbursement
17 June, 2013 by Dylan Bushell-EmblingThe UK’s NICE has issued a draft decision recommending reimbursement of Iluvien, an ocular insert developed by pSivida (ASX:PVA), for pseudophakic DME patients.
QRxPharma wins US patent for opioid compounds
13 June, 2013QRxPharma (ASX:QRX) has been granted a US patent covering linking morphine and oxycodone molecules to form a more potent hybrid compound.
Updates on agricultural biotechnology made easy
13 June, 2013The Agricultural Biotechnology Council of Australia (ABCA) invites you to join its email list to receive regular updates on current and emerging issues in agricultural biotechnology in Australia.
UBI wins Vic government manufacturing award
12 June, 2013 by Dylan Bushell-EmblingUniversal Biosensors (ASX:UBI) has picked up a Victorian government manufacturing award recognising innovative use of technology in its production processes.
Australian doctors back asthma system, says iSonea
12 June, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has released the results of a survey suggesting that 80% of Australian GPs and 62% of paediatricians would recommend its upcoming mobile wheeze-monitoring system.
Applications invited for export awards
11 June, 2013The Australian Export Awards has commenced its 2013 campaign to crown Australia’s exporting success stories.
New site for bioscience businesses
11 June, 2013A new purpose-built technology hub to support emerging high-tech businesses has been established in South Australia.
ResMed files patent suit against Chinese vendor
07 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has filed a US patent violation lawsuit against Chinese manufacturer BMC and is seeking to have the company added to its pending ITC case.
